These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1312732)

  • 1. Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists.
    Paul IA; Trullas R; Skolnick P; Nowak G
    Psychopharmacology (Berl); 1992; 106(2):285-7. PubMed ID: 1312732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 2. Chronic treatment results in downregulation of cortical beta-adrenoceptors.
    Karolewicz B; Bruce KH; Lee B; Paul IA
    Eur J Pharmacol; 1999 May; 372(3):215-20. PubMed ID: 10395014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions.
    Trullas R; Skolnick P
    Eur J Pharmacol; 1990 Aug; 185(1):1-10. PubMed ID: 2171955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex.
    Skolnick P; Miller R; Young A; Boje K; Trullas R
    Psychopharmacology (Berl); 1992; 107(4):489-96. PubMed ID: 1534910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid.
    Nowak G; Trullas R; Layer RT; Skolnick P; Paul IA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1380-6. PubMed ID: 8099620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression.
    Harkin A; Nally R; Kelly JP; Leonard BE
    J Neural Transm (Vienna); 2000; 107(10):1213-27. PubMed ID: 11129111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.
    Skolnick P; Layer RT; Popik P; Nowak G; Paul IA; Trullas R
    Pharmacopsychiatry; 1996 Jan; 29(1):23-6. PubMed ID: 8852530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of antidepressants on GABAB and beta-adrenergic receptors in rat cerebral cortex.
    McManus DJ; Greenshaw AJ
    Biochem Pharmacol; 1991 Sep; 42(8):1525-8. PubMed ID: 1656988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoflurane reduces N-methyl-D-aspartate toxicity in vivo in the rat cerebral cortex.
    Harada H; Kelly PJ; Cole DJ; Drummond JC; Patel PM
    Anesth Analg; 1999 Dec; 89(6):1442-7. PubMed ID: 10589624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of MK-801 and the NMDA receptor: further evidence for reduced sensitivity of the primary acceptor site from studies with the cortical wedge preparation.
    Beart PM; Lodge D
    J Pharm Pharmacol; 1990 May; 42(5):354-5. PubMed ID: 1976785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ; Bian JT; Bhargava HN
    Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic glycine treatment desensitizes the behavioral response to 1-aminocyclopropanecarboxylic acid (ACPC), a partial agonist at the strychnine-insensitive glycine site of the NMDA receptor complex.
    Nowak G; Li Y; Paul IA
    J Neural Transm (Vienna); 2000; 107(2):123-31. PubMed ID: 10847554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of MK-801 and imipramine on beta-adrenergic and 5-HT2 receptors in the chronic mild stress model of depression in rats.
    Klimek V; Papp M
    Pol J Pharmacol; 1994; 46(1-2):67-9. PubMed ID: 7981774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dibenzocycloalkenimine (MK-801) stimulates phosphoinositide hydrolysis in rat cerebral cortical slices).
    Ormandy GC; Li X; Jope RS
    Neuropharmacology; 1990 Aug; 29(8):779-82. PubMed ID: 2177162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid down-regulation of beta-adrenergic receptors evoked by combined forced swimming test and CGP 37849--a competitive antagonist of NMDA receptors.
    Wedzony K; Klimek V; Nowak G
    Pol J Pharmacol; 1995; 47(6):537-40. PubMed ID: 8868377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements.
    Grimwood S; Foster AC; Kemp JA
    Br J Pharmacol; 1991 Jun; 103(2):1385-92. PubMed ID: 1832067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of chronic imipramine administration on beta-adrenoceptor density on rat lymphocytes.
    Chalecka-Franaszek E; Vetulani J
    Pol J Pharmacol Pharm; 1986; 38(4):385-90. PubMed ID: 3022259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rise in zinc affinity for the NMDA receptor evoked by chronic imipramine is species-specific.
    Szewczyk B; Kata R; Nowak G
    Pol J Pharmacol; 2001; 53(6):641-5. PubMed ID: 11985339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Aminocyclopropane-carboxylic acid reduces NMDA-induced hippocampal neurodegeneration in vivo.
    Zapata A; Capdevila JL; Viu E; Trullas R
    Neuroreport; 1996 Jan; 7(2):397-400. PubMed ID: 8730790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.